![](https://www.thebrighterside.news/uploads/2024/04/95ac29_1fa318faf46e48a1a8f0d43d462b1849mv2.jpg?auto=webp&auto=webp&optimize=high&quality=70&width=1440)
Sickle Cell Anemia
DiscoveriesWorld’s first CRISPR gene-editing treatment just received regulatory approval
Casgevy is designed to address two debilitating blood disorders: sickle cell disease (SCD) and transfusion-dependent beta-thalassemia.
Joseph Shavit![](https://www.thebrighterside.news/uploads/2024/04/95ac29_c08fad92a77b4b538b5f4e9999b236d9mv2-scaled.jpeg?auto=webp&auto=webp&optimize=high&quality=70&width=1440)
![](https://www.thebrighterside.news/uploads/2024/04/95ac29_1fa318faf46e48a1a8f0d43d462b1849mv2.jpg?auto=webp&auto=webp&optimize=high&quality=70&width=1440)